Nicotinamide Riboside Doubled NAD+ but Failed to Boost Memory
A supplement doubled a key molecule in the blood, and memory didn't budge. In a 12-week randomized trial of older adults with amnestic mild cognitive impairment, nicotinamide riboside raised NAD+ twofold but did not improve cognition, total brain blood flow, or blood pressure. There was one tantalizing exploratory hint of increased hippocampal blood flow, but it's far from proof. Here's what the study really shows, where its limits are, and what it means if you're thinking about buying an NAD+ booster.
A Year of Spermidine Raised Precuneus Blood Flow, Not Memory
A 12-month trial of 0.9 mg/day spermidine in older adults with subjective cognitive decline found higher blood flow in the precuneus and steadier white-matter integrity versus placebo. But this exploratory MRI analysis of 75 SmartAge participants showed no changes in brain volume, cortical thickness, or white-matter hyperintensities. Crucially, the imaging changes weren't linked to memory, and the parent trial found no memory benefit. Here's what the signal might mean, what it doesn't, and the practical details on dose and food sources.